Literature DB >> 3088175

[The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections].

M Sawaki, R Mikami, K Mikasa, M Kunimatsu, S Ito, N Narita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3088175     DOI： 10.11150/kansenshogakuzasshi1970.60.45

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN： 0387-5911


× No keyword cloud information.
  7 in total

1.  Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis.

Authors:  K Kawamura-Sato; Y Iinuma; T Hasegawa; T Horii; T Yamashino; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 2.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

3.  Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach.

Authors:  Yusuf Nalca; Lothar Jänsch; Florian Bredenbruch; Robert Geffers; Jan Buer; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.

Authors:  K Oishi; F Sonoda; S Kobayashi; A Iwagaki; T Nagatake; K Matsushima; K Matsumoto
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.

Authors:  T Fujii; J Kadota; K Kawakami; K Iida; R Shirai; M Kaseda; S Kawamoto; S Kohno
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

6.  Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro.

Authors:  K Morikawa; F Oseko; S Morikawa; K Iwamoto
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 7.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.